Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Astaxanthin may reduce inflammation in women with PCOS, but doesn't significantly improve symptoms.

Early treatment improved COVID-19 outcomes, and spironolactone helped reduce risks in females with high androgen levels.

Polycystic ovary syndrome (PCOS) affects about 10% of women, is often linked to obesity and family history, and can cause irregular periods, fertility issues, and other symptoms. It's usually managed with lifestyle changes, weight loss, and medication.

Azathioprine may help with severe hair loss, a new topical treatment could counteract hair thinning, and trichoscopy can diagnose hair-pulling disorder effectively.

Researchers created a simple tool to predict bladder blockage from prostate enlargement using urine flow rate and prostate volume.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Men face more severe COVID-19 outcomes, while women are more likely to have long-term symptoms.

Menopause affects skin and hair, and more research is needed for effective treatments.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

Free testosterone is the most common hormone marker in PCOS, and age affects DHEAS levels.

Eating the right nutrients can improve hair health, but taking extra supplements usually doesn't help unless you have a deficiency.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Turkish women with hirsutism experience lower quality of life, especially those with PCOS, regardless of hair growth severity.

A woman with anorexia and Cushing's syndrome improved after tumor removal, highlighting the need to consider hormonal issues in psychiatric conditions.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

The document concludes that hair loss in women is complex, often linked to aging, health conditions, and nutritional deficiencies, and emotional impacts should not be underestimated.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Two patients with lupus had an unusual type of hair loss not typical for the disease but improved with treatment.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

New acne treatments show promise as alternatives to traditional therapies.

Skin conditions can signal diabetes and insulin resistance.

Melatonin improved mental health and metabolism in women with PCOS.

Certain MC4R gene variants are linked to higher BMI in obese women with PCOS but do not cause PCOS.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

Early treatment of acne is crucial to prevent scarring and psychological effects.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.